Literature DB >> 18319327

Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation.

Junghee Lee1, Sean Hagerty, Kerry A Cormier, Jinho Kim, Andrew L Kung, Robert J Ferrante, Hoon Ryu.   

Abstract

Chromatin remodeling is tightly controlled under physiological conditions. Alterations in chromatin structure are involved in the pathogenesis of neuronal systems. We found that the monoallelic deletion of CREB binding protein (CBP) results in the induction of ERG-associated protein with SET domain (ESET) and increases trimethylation of histone H3 (K9) and condensation of pericentromeric heterochromatin structure in neurons. Nested deletion and mutational analysis of the ESET promoter further demonstrated that the Ets-2 transcription factor regulates transcriptional activity of the ESET gene. In CBP+/- mice, Ets-2 occupancy in the ESET promoter DNA was markedly elevated. Our results suggest that CBP is a transcriptional repressor of ESET gene expression by limiting Ets-2 transcriptional activity, while CBP siRNA enhances basal and Ets-2-dependent ESET transcriptional activity. Altered expression of the ESET gene and hypertrimethylation of H3 (K9) correlate with striatal neuron atrophy and dysfunction in CBP+/- mice. These results establish an alternative pathway that loss of CBP leads to the pericentric heterochromatin condensation through ESET expression and trimethylation of H3 (K9).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18319327      PMCID: PMC2900890          DOI: 10.1093/hmg/ddn067

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  32 in total

1.  p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter.

Authors:  G Jayaraman; R Srinivas; C Duggan; E Ferreira; S Swaminathan; K Somasundaram; J Williams; C Hauser; M Kurkinen; R Dhar; S Weitzman; G Buttice; B Thimmapaya
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

2.  Differential subnuclear localization and replication timing of histone H3 lysine 9 methylation states.

Authors:  Rong Wu; Anna V Terry; Prim B Singh; David M Gilbert
Journal:  Mol Biol Cell       Date:  2005-03-23       Impact factor: 4.138

3.  Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons.

Authors:  Hoon Ryu; Junghee Lee; Soren Impey; Rajiv R Ratan; Robert J Ferrante
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-16       Impact factor: 11.205

4.  Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease.

Authors:  Gabriella Gardian; Susan E Browne; Dong-Kug Choi; Peter Klivenyi; Jason Gregorio; James K Kubilus; Hoon Ryu; Brett Langley; Rajiv R Ratan; Robert J Ferrante; M Flint Beal
Journal:  J Biol Chem       Date:  2004-10-19       Impact factor: 5.157

5.  ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.

Authors:  Pablo Helguera; Alejandra Pelsman; Gustavo Pigino; Ernst Wolvetang; Elizabeth Head; Jorge Busciglio
Journal:  J Neurosci       Date:  2005-03-02       Impact factor: 6.167

6.  CBP histone acetyltransferase activity is a critical component of memory consolidation.

Authors:  Edward Korzus; Michael G Rosenfeld; Mark Mayford
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

7.  Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer.

Authors:  C V Gunther; B J Graves
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

8.  Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease.

Authors:  Robert J Ferrante; Hoon Ryu; James K Kubilus; Santosh D'Mello; Katharine L Sugars; Junghee Lee; Peiyuan Lu; Karen Smith; Susan Browne; M Flint Beal; Bruce S Kristal; Irina G Stavrovskaya; Sandra Hewett; David C Rubinsztein; Brett Langley; Rajiv R Ratan
Journal:  J Neurosci       Date:  2004-11-17       Impact factor: 6.167

9.  Uncoupling global and fine-tuning replication timing determinants for mouse pericentric heterochromatin.

Authors:  Rong Wu; Prim B Singh; David M Gilbert
Journal:  J Cell Biol       Date:  2006-07-10       Impact factor: 10.539

Review 10.  Linking the epigenetic 'language' of covalent histone modifications to cancer.

Authors:  S B Hake; A Xiao; C D Allis
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

View more
  18 in total

1.  Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.

Authors:  Yan Jiang; Anouch Matevossian; Yin Guo; Schahram Akbarian
Journal:  Neuropharmacology       Date:  2010-09-30       Impact factor: 5.250

2.  Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B.

Authors:  Yan Jiang; Mira Jakovcevski; Rahul Bharadwaj; Caroline Connor; Frederick A Schroeder; Cong L Lin; Juerg Straubhaar; Gilles Martin; Schahram Akbarian
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

3.  Epigenetic mechanisms of Rubinstein-Taybi syndrome.

Authors:  Elizabeth Park; Yunha Kim; Hyun Ryu; Neil W Kowall; Junghee Lee; Hoon Ryu
Journal:  Neuromolecular Med       Date:  2014-01-01       Impact factor: 3.843

Review 4.  Epigenetic mechanisms of neurodegeneration in Huntington's disease.

Authors:  Junghee Lee; Yu Jin Hwang; Ki Yoon Kim; Neil W Kowall; Hoon Ryu
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

5.  In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level.

Authors:  Insun Park; Yu Jin Hwang; TaeHun Kim; Ambily Nath Indu Viswanath; Ashwini M Londhe; Seo Yun Jung; Kyoung Mi Sim; Sun-Joon Min; Ji Eun Lee; Jihye Seong; Yun Kyung Kim; Kyoung Tai No; Hoon Ryu; Ae Nim Pae
Journal:  J Comput Aided Mol Des       Date:  2017-09-06       Impact factor: 3.686

6.  CLLD8/KMT1F is a lysine methyltransferase that is important for chromosome segregation.

Authors:  Claire Falandry; Geneviève Fourel; Vincent Galy; Tutik Ristriani; Béatrice Horard; Elsa Bensimon; Gilles Salles; Eric Gilson; Frédérique Magdinier
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

7.  Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington's disease.

Authors:  J Lee; Y J Hwang; J H Boo; D Han; O K Kwon; K Todorova; N W Kowall; Y Kim; H Ryu
Journal:  Cell Death Differ       Date:  2011-05-06       Impact factor: 15.828

8.  Activation of Ets-2 by oxidative stress induces Bcl-xL expression and accounts for glial survival in amyotrophic lateral sclerosis.

Authors:  Junghee Lee; Mari Kannagi; Robert J Ferrante; Neil W Kowall; Hoon Ryu
Journal:  FASEB J       Date:  2009-01-29       Impact factor: 5.191

9.  Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington's disease.

Authors:  Junghee Lee; Yu Jin Hwang; Jong-Yeon Shin; Won-Chul Lee; Jinhong Wie; Ki Yoon Kim; Min Young Lee; Daehee Hwang; Rajiv R Ratan; Ae Nim Pae; Neil W Kowall; Insuk So; Jong-Il Kim; Hoon Ryu
Journal:  Acta Neuropathol       Date:  2013-03-02       Impact factor: 17.088

Review 10.  PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks.

Authors:  Lindsey A Baker; C David Allis; Gang G Wang
Journal:  Mutat Res       Date:  2008-07-17       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.